ask="0.3200"
ask_size="9200"
average_daily_volume="1558900"
bid="0.3000"
bid_size="44300"
book_value="0.1680"
change="+0.0059"
change_from_200_day_moving_average="-0.0520"
change_from_50_day_moving_average="-0.0095"
change_from_52_week_high="-0.8716"
change_From_52_week_low="0.0184"
change_in_percent="+1.9504%"
close="0.3084"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2040"
ebitda="-41.64M"
eps_estimate_current_year="-0.1300"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1100"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.3099"
high_52_weeks="1.1800"
last_trade_date="1/4/2017"
last_trade_price="0.3084"
last_trade_size="14830"
last_trade_time="4:00pm"
low="0.3045"
low_52_weeks="0.2900"
market_capitalization="79.30M"
moving_average_200_day="0.3604"
moving_average_50_day="0.3179"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.2500"
open="0.3050"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-14.4374%"
percent_change_from_50_day_moving_average="-2.9819%"
percent_change_from_52_week_high="-73.8644%"
percent_change_from_52_week_low="+6.3448%"
previous_close="0.3025"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.8006"
price_per_sales="1.4280"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.5700"
stock_exchange="NCM"
symbol="PPHM"
volume="777897"
weeks_range_52="0.2900 - 1.1800"
